NASDAQ Equity Snapshot
SCNI Weekly Equity Report
Scinai Immunotherapeutics Ltd
What the company does
Scinai Immunotherapeutics Ltd is a cutting-edge biotechnology company specializing in the development of innovative immunotherapy solutions aimed at treating cancer and autoimmune disorders. Utilizing its proprietary immune modulation platform, Scinai is advancing a robust clinical pipeline that focuses on delivering transformative therapies to improve patient outcomes. With a highly experienced leadership team and a commitment to rigorous research, the company is well-positioned to capitalize on the growing demand for advanced immunotherapeutics in the global healthcare landscape. Strategic partnerships further enhance Scinai's potential for significant growth, establishing it as a key player in the biopharmaceutical sector.
What the weekly tape is saying
SCNI closed the latest completed week at 0.33 USD. The 4-week return is -38.3% and the 12-week return is -53.2%. Trend Signal is inactive, Market Dynamics is -0.57. Setup signature: Risk-first tape with a 5/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.74 USD
- Vs Trend Line
- -55.0%
- Fair Value
- 4.00 USD
- Vs Fair Value
- -91.7%
- 52W High
- 3.48 USD
- 52W Low
- 0.30 USD
- Drawdown
- -90.5%
- Range Position
- 1.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 1011 of 1038
- Sector Percentile
- 2.6%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.57
- 4W MD Change
- -185.4%
- Relative Strength
- -75.61
- 4W RS Change
- -14.7%
- Expectation
- Negative
- Probability
- 38.87%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.3M
- 13W Average
- 16.5M
- 52W Average
- 5.6M
- Vs 13W
- 0.1x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.8%
- 52W Volatility
- 12.2%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 8.0% / -9.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 1.7M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.33 USD | -19.7% | 0.74 USD | 4.00 USD | -0.57 | -75.61 | 2.3M | Off |
| 5 Jun 2026 | 0.41 USD | -8.4% | 0.76 USD | 4.09 USD | -0.28 | -70.08 | 2.1M | Off |
| 29 May 2026 | 0.45 USD | -2.4% | 0.78 USD | 4.17 USD | -0.03 | -70.06 | 961.9K | Off |
| 22 May 2026 | 0.46 USD | -14.0% | 0.81 USD | 4.28 USD | 0.28 | -69.76 | 1.5M | Off |
| 15 May 2026 | 0.54 USD | -5.6% | 0.84 USD | 4.39 USD | 0.66 | -65.90 | 735.5K | Off |
| 8 May 2026 | 0.57 USD | -20.0% | 0.87 USD | 4.51 USD | 0.57 | -65.46 | 886.7K | Off |
| 1 May 2026 | 0.71 USD | -3.7% | 0.90 USD | 4.63 USD | 0.55 | -56.08 | 4.2M | Off |
| 24 Apr 2026 | 0.74 USD | 32.8% | 0.92 USD | 4.75 USD | 0.52 | -55.37 | 201.0M | Off |
| 17 Apr 2026 | 0.56 USD | -4.4% | 0.94 USD | 4.87 USD | 0.26 | -66.70 | 112.6K | Off |
| 10 Apr 2026 | 0.58 USD | -3.2% | 0.97 USD | 4.99 USD | 0.35 | -64.00 | 199.4K | Off |
| 2 Apr 2026 | 0.60 USD | -0.2% | 1.00 USD | 5.10 USD | 0.34 | -62.08 | 758.2K | Off |
| 27 Mar 2026 | 0.60 USD | -15.1% | 1.03 USD | 5.21 USD | 0.44 | -61.86 | 90.4K | Off |
| 20 Mar 2026 | 0.71 USD | -0.4% | 1.07 USD | 5.34 USD | 0.65 | -57.96 | 51.3K | Off |
| 13 Mar 2026 | 0.71 USD | -8.9% | 1.09 USD | 5.48 USD | 0.76 | -60.19 | 86.1K | Off |